Literature DB >> 9607562

Nitric oxide inhibits APO-1/Fas-mediated cell death.

S Dimmeler1, J Haendeler, A Sause, A M Zeiher.   

Abstract

Activation of the cysteine protease caspases, which are homologous to the product of Caenorhabditis elegans cell-death gene ced 3, is required to mediate APO-1/Fas-induced apoptosis. We report here that nitric oxide (NO) released by exogenous NO donors, as well as NO endogenously derived by transfection with the inducible NO synthase, substantially suppresses APO-1/Fas-triggered cell death of Jurkat cells. The inhibitory NO effect was independent of cGMP, because 8-bromo-cGMP did not influence APO-1/Fas-mediated apoptosis. In contrast, NO interferes with the APO-1/Fas-induced stimulation of caspases. NO inhibits the proteolytic cleavage of caspase-3 (CPP32) into its active subunits, thereby suppressing caspase-3 activity. In addition, NO potently inhibits apoptosis induction by overexpresssion of the death domain protein FADD or the immediate downstream target caspase-8. These results suggest that NO modulates the proteolytic cascade upstream of caspase-3. Indeed, NO specifically S-nitrosylates caspase-8 and caspase-1 and thereby may prevent activation of the proteolytic cascade. The NO-mediated increase in the resistance toward induction of apoptosis may play a major role in mediating immune responses, as well as in the pathogenesis of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607562

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  12 in total

Review 1.  Nitric oxide, cell death, and heart failure.

Authors:  Jun-ichi Oyama; Stefan Frantz; Charles Blais; Ralph A Kelly; Todd Bourcier
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

2.  Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals.

Authors:  C C Chiueh; T Andoh; A R Lai; E Lai; G Krishna
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis.

Authors:  A L Scarim; M Arnush; L A Blair; J Concepcion; M R Heitmeier; D Scheuner; R J Kaufman; J Ryerse; R M Buller; J A Corbett
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Nitric oxide induces apoptosis in NALM-6, a leukaemia cell line with low cyclin E protein levels.

Authors:  M Mozart; R Scuderi; F Celsing; M Aguilar-Santelises
Journal:  Cell Prolif       Date:  2001-12       Impact factor: 6.831

Review 5.  S-nitrosylation: NO-related redox signaling to protect against oxidative stress.

Authors:  Junhui Sun; Charles Steenbergen; Elizabeth Murphy
Journal:  Antioxid Redox Signal       Date:  2006 Sep-Oct       Impact factor: 8.401

6.  Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases.

Authors:  Birgit Zech; Roman Köhl; Andreas von Knethen; Bernhard Brüne
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

7.  Changes of sFas and sFasL, oxidative stress markers in serum and follicular fluid of patients undergoing IVF.

Authors:  Aslıhan Pekel; Aymelek Gönenç; Nilgün Öztürk Turhan; Hasan Kafalı
Journal:  J Assist Reprod Genet       Date:  2014-12-09       Impact factor: 3.412

8.  Nitric oxide and promotion of cardiac myocyte apoptosis.

Authors:  Péter Andréka; Thanh Tran; Keith A Webster; Nanette H Bishopric
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

Review 9.  Nitrosothiols in the immune system: signaling and protection.

Authors:  Pablo Hernansanz-Agustín; Alicia Izquierdo-Álvarez; Almudena García-Ortiz; Sales Ibiza; Juan M Serrador; Antonio Martínez-Ruiz
Journal:  Antioxid Redox Signal       Date:  2012-08-17       Impact factor: 8.401

10.  Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.

Authors:  Laurence Booth; Jane L Roberts; Nichola Cruickshanks; Steven Grant; Andrew Poklepovic; Paul Dent
Journal:  Mol Cancer Ther       Date:  2014-08-07       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.